companydata.dkcompanydata.dk

Hoba Therapeutics ApS: Financial statements 2024

CVR: 38231170

Source: annual report 2024, Danish Business Authority

01/04/2023 – 31/03/2024

Hoba Therapeutics ApS (CVR 38231170) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -20,860,206 and a net result of DKK -27,806,718 compared with DKK -13,930,313 the year before. Equity in the 2024 report amounted to DKK 69,070,189. The solvency ratio was 75.5%. The company had 8 employees in the financial year.

Gross Profit
DKK -20,860,206
Profit/Loss
DKK -27,806,718
Equity
DKK 69,070,189
Total Assets
DKK 91,475,854
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024--20.9M-27.8M69.1M8
2023--9.4M-13.9M-32.9M6
20220-7.2M-10.9M-19M3
2021-1.4M-1.9M8.2M3
2020-839K-1.6M10.1M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Gunnar Magnus Severus Modée Persson joins the board of Hoba Therapeutics ApSSep 10, 2024

As of September 10, 2024, Gunnar Magnus Severus Modée Persson has joined the board of directors of Hoba Therapeutics ApS.

Lene Gerlach leaves the board of Hoba Therapeutics ApSSep 2, 2024

As of September 2, 2024, Lene Gerlach has left the board of directors of Hoba Therapeutics ApS.

Jean Marcel André Combalbert joins the board of Hoba Therapeutics ApSMar 1, 2024

As of March 1, 2024, Jean Marcel André Combalbert has joined the board of directors of Hoba Therapeutics ApS.

Amanda Hayward leaves the board of Hoba Therapeutics ApSMar 1, 2024

As of March 1, 2024, Amanda Hayward has left the board of directors of Hoba Therapeutics ApS.

About Hoba Therapeutics ApS

Hoba Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade. The board consists of Gonçalo Nuno Nunes da Silva Rebelo de Andrade (chair) and Gunnar Magnus Severus Modée Persson. The company's owners include Novo Holdings A/S, Danmarks Eksport- og Investeringsfond and EIC Fund. The company has 2 employees (2026). In 2026, the company reported a gross profit of DKK -61,710,701 and a net result of DKK -67,693,868 compared with DKK -43,008,287 the year before. Equity in the 2026 report amounted to DKK 1,143,899.

Source: annual report 2026, Danish Business Authority